224 results on '"Magierowska, Katarzyna"'
Search Results
2. The mitochondria-targeted sulfide delivery molecule attenuates drugs-induced gastropathy. Involvement of heme oxygenase pathway.
3. Mitochondria-targeted hydrogen sulfide donors versus acute oxidative gastric mucosal injury
4. Impact of Vagotomy on Postoperative Weight Loss, Alimentary Intake, and Enterohormone Secretion After Bariatric Surgery in Experimental Translational Models
5. Physiological healing of chronic gastric ulcer is not impaired by the hydrogen sulphide (H2S)-releasing derivative of acetylsalicylic acid (ATB-340): functional and proteomic approaches.
6. Commonly observed RNF43 mutations retain functionality in attenuating Wnt/β-catenin signaling and unlikely confer Wnt-dependency onto colorectal cancers
7. Hydrogen Sulfide-Releasing Indomethacin-Derivative (ATB-344) Prevents the Development of Oxidative Gastric Mucosal Injuries
8. Mechanisms of curcumin-induced gastroprotection against ethanol-induced gastric mucosal lesions
9. Can exercise affect the course of inflammatory bowel disease? Experimental and clinical evidence
10. <scp>CO</scp>in Gastrointestinal Physiology and Protection
11. Nitric oxide, afferent sensory nerves, and antioxidative enzymes in the mechanism of protection mediated by tricarbonyldichlororuthenium(II) dimer and sodium hydrosulfide against aspirin-induced gastric damage
12. Emerging role of carbon monoxide in regulation of cellular pathways and in the maintenance of gastric mucosal integrity
13. Hydrogen Sulfide and Carbon Monoxide Protect Gastric Mucosa Compromised by Mild Stress Against Alendronate Injury
14. Carbon monoxide released from its pharmacological donor, tricarbonyldichlororuthenium (II) dimer, accelerates the healing of pre‐existing gastric ulcers
15. CO in Gastrointestinal Physiology and Protection
16. Tu1534: INTESTINAL ALKALINE PHOSPHATASE THERAPY COUNTERACTS THE INTENSIFICATION OF COLITIS IN OBESE MICE SUBJECTED TO FORCED TREADMILL EXERCISE BY SHAPING THE INTESTINAL MICROBIOTA AND ATTENUATING OF PRO-INFLAMMATORY AND OXIDATIVE STRESS BIOMARKERS
17. Sa1129: THERAPEUTIC EFFECT OF MITOCHONDRIA-TARGETING HYDROGEN SULFIDE PRODRUG, AP39 IN THE HEALING OF CHRONIC GASTRIC ULCERS
18. Mo1618: EXPRESSION OF TIGHT JUNCTION PROTEINS IS MODULATED BY MATERNAL OBESITY INDUCED BY DIFFERENT DIET PROGRAM. EVIDENCE FROM INTESTINE OF PREGNANT DAMS AND THEIR MALE AND FEMALE RAT OFFSPRING
19. Tu1167b: INTRODUCTION TO THE THERAPEUTIC POTENTIAL OF CARBON MONOXIDE (CO) RELEASED FROM PHARMACOLOGICAL DONORS AGAINST BARRETT'S METAPLASIA AND ESOPHAGEAL ADENOCARCINOMA (EAC) DEVELOPMENT
20. Role of Obesity, Physical Exercise, Adipose Tissue-Skeletal Muscle Crosstalk and Molecular Advances in Barrett’s Esophagus and Esophageal Adenocarcinoma
21. Sa1208 THE GUT-SPARING EFFECTS OF ROFECOXIB, A CYCLOOXYGENASE-2 INHIBITOR, AND RESVERATROL, A PREFERENTIAL CYCLOOXYGENASE-1 INHIBITOR IN EXPERIMENTAL COLITIS, ARE ELIMINATED BY THE SIMULTANEOUS BLOCKADE OF NITRIC OXIDE SYNTHASE
22. Insight into preventive effects of anti-oxidative carbon monoxide (CO) against the chronic inflammation-induced esophageal metaplasia development and progression
23. Microbiome Profile and Molecular Pathways Alterations in Gastrointestinal Tract by Hydrogen Sulfide-Releasing Nonsteroidal Anti-Inflammatory Drug (ATB-352): Insight into Possible Safer Polypharmacy
24. Hydrogen sulfide as a modulator of mitochondrial activity in the protection against oxidative NSAIDs-induced gastric injury
25. Participation of the intestinal microbiota in the mechanism of beneficial effect of treatment with symbiotic syngut on experimental colitis under stress conditions
26. Novel Hydrogen Sulfide (H2S)-Releasing BW-HS-101 and Its Non-H2S Releasing Derivative in Modulation of Microscopic and Molecular Parameters of Gastric Mucosal Barrier
27. Fr129 IMPACT OF NOVEL HYDROGEN SULFIDE-RELEASING KETOPROFEN (ATB-352) ON MOLECULAR PATHWAYS AND MICROBIOME PROFILE IN GASTROINTESTINAL (GI) TRACT WITH POSSIBLE DEVELOPMENT OF GI-SAFE POLYPHARMACY WITH OTHER NON-STEROIDAL ANTI INFLAMMATORY DRUGS (NSAIDS)
28. Fr157 DECREASED ACTIVITY OF ENDOGENOUS HYDROGEN SULFIDE (H2S)-PRODUCING ENZYME IN BARRETT'S METAPLASIA PROGRESSION WITH POSSIBLE MODULATION OF METALLOPEPTIDASE INHIBITOR (TIMP1) AND SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 (STAT3) PATHWAYS
29. Sa629 THE COMBINATION OF ALKALINE PHOSPHATASE TREATMENT WITH VOLUNTARY PHYSICAL ACTIVITY AMELIORATES THE INFLAMMATION OF LIVER AND ADIPOSE TISSUE IN MURINE COLITIS WITH ABDOMINAL OBESITY. IMPORTANCE OF CYTOKINES, OXIDATIVE STRESS AND ADIPOMYOKINES
30. Su241 APELIN/AJP SYSTEM PROTECTS THE GASTRIC MUCOSA AGAINST ISCHEMIA-REPERFUSION INJURY VIA ACTIVATION OF CNOS/NO SYSTEM, SENSORY NEUROPEPTIDES AND SUPPRESSION OF OXIDATIVE STRESS
31. Intestinal Alkaline Phosphatase Combined with Voluntary Physical Activity Alleviates Experimental Colitis in Obese Mice. Involvement of Oxidative Stress, Myokines, Adipokines and Proinflammatory Biomarkers
32. Organic carbon monoxide prodrug, BW-CO-111, in protection against chemically-induced gastric mucosal damage
33. Su1368 NOVEL APPROACH ON PEPTIC ULCER PHARMACOLOGY: THERAPEUTIC EFFECT OF MITOCHONDRIA-TARGETED HYDROGEN SULFIDE MOLECULES
34. 934 GERD-INDUCED ALTERATIONS IN HYDROGEN SULFIDE SIGNALING AS THE FUNDAMENTAL MECHANISM OF BARRETT'S ESOPHAGUS PATHOGENESIS
35. Molecular Profile of Barrett’s Esophagus and Gastroesophageal Reflux Disease in the Development of Translational Physiological and Pharmacological Studies
36. Alternative Therapy in the Prevention of Experimental and Clinical Inflammatory Bowel Disease. Impact of Regular Physical Activity, Intestinal Alkaline Phosphatase and Herbal Products
37. Evidence for Cytoprotective Effect of Carbon Monoxide Donor in the Development of Acute Esophagitis Leading to Acute Esophageal Epithelium Lesions
38. 834 EFFECT OF MATERNAL OBESITY INDUCED BY DIFFERENT DIET PROGRAM ON THE PLASMA LEVELS OF APPETITE HORMONES AND INTESTINAL EXPRESSION OF ADIPOKINES AND ADIPO RECEPTORS 1 AND 2 IN MALE AND FEMALE RAT OFFSPRING
39. Mo1034 INTESTINAL PROTECTION INDUCED BY TREATMENT WITH ALKALINE PHOSPHATASE ON THE SEVERITY OF EXPERIMENTAL COLITIS IN OBESE MICE SUBJECTED TO FORCED TREADMILL RUNNING. ROLE OF PROINFLAMMATORY BIOMARKERS, INTESTINAL BARRIER PROTEINS AND OXIDATIVE STRESS
40. Su1122 DEVELOPMENT OF BARRETT'S ESOPHAGUS (BE) AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) EXPERIMENTAL MODELS FOR TRANSLATIONAL PHARMACOLOGICAL STUDIES RELATED TO THE POSSIBLE NOVEL TREATMENT METHODS OF THESE PATHOLOGIES
41. Interaction of epidermal growth factor with COX-2 products and peroxisome proliferator-activated receptor-γ system in experimental rat Barrett’s esophagus
42. Oxidative gastric mucosal damage induced by ischemia/reperfusion and the mechanisms of its prevention by carbon monoxide-releasing tricarbonyldichlororuthenium (II) dimer
43. Effect of forced physical activity on the severity of experimental colitis in normal weight and obese mice : involvement of oxidative stress and proinflammatory biomarkers
44. Exploiting Significance of Physical Exercise in Prevention of Gastrointestinal Disorders
45. Resveratrol: 'wrong' blocker of constitutive cyclooxygenase or 'good' free radicals scavenger? Investigations on resveratrol action in experimental model of gastric damage
46. Effect of Forced Physical Activity on the Severity of Experimental Colitis in Normal Weight and Obese Mice. Involvement of Oxidative Stress and Proinflammatory Biomarkers
47. 281 – Role of Endogenous and Exogenous Carbon Monoxide (CO) Released from Co Donor in Esophagoprotection Against Experimental Reflux Esophagitis. Importance of Heme Oxygenase-1 (HO-1), Prostaglandins and Sensory Afferent Neuropeptides
48. Time-dependent course of gastric ulcer healing and molecular markers profile modulated by increased gastric mucosal content of carbon monoxide released from its pharmacological donor
49. Su1102 – Carbon Monoxide Released from Its Pharmacological Donor Prevents Gastric Mucosa Against Oxidative Ischemi/Areperfusion-Induced Injury by the Involvement of the Atpdependent Potassium Channels and Nitric Oxide Synthase Activity
50. Curcumin: A Potent Protectant against Esophageal and Gastric Disorders
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.